536 related articles for article (PubMed ID: 23979875)
1. Preferences for colorectal cancer screening techniques and intention to attend: a multi-criteria decision analysis.
Hummel JM; Steuten LG; Groothuis-Oudshoorn CJ; Mulder N; Ijzerman MJ
Appl Health Econ Health Policy; 2013 Oct; 11(5):499-507. PubMed ID: 23979875
[TBL] [Abstract][Full Text] [Related]
2. What influences the decision to participate in colorectal cancer screening with faecal occult blood testing and sigmoidoscopy?
van Dam L; Korfage IJ; Kuipers EJ; Hol L; van Roon AH; Reijerink JC; van Ballegooijen M; van Leerdam ME
Eur J Cancer; 2013 Jul; 49(10):2321-30. PubMed ID: 23571149
[TBL] [Abstract][Full Text] [Related]
3. The effect of presenting information about invasive follow-up testing on individuals' noninvasive colorectal cancer screening participation decision: results from a discrete choice experiment.
Benning TM; Dellaert BG; Severens JL; Dirksen CD
Value Health; 2014 Jul; 17(5):578-87. PubMed ID: 25128051
[TBL] [Abstract][Full Text] [Related]
4. Cost-effectiveness analysis of colorectal cancer screening methods in Iran.
Allameh Z; Davari M; Emami MH
Arch Iran Med; 2011 Mar; 14(2):110-4. PubMed ID: 21361717
[TBL] [Abstract][Full Text] [Related]
5. Eliciting population preferences for mass colorectal cancer screening organization.
Nayaradou M; Berchi C; Dejardin O; Launoy G
Med Decis Making; 2010; 30(2):224-33. PubMed ID: 19692710
[TBL] [Abstract][Full Text] [Related]
6. National Survey of Patient Factors Associated with Colorectal Cancer Screening Preferences.
Zhu X; Parks PD; Weiser E; Fischer K; Griffin JM; Limburg PJ; Finney Rutten LJ
Cancer Prev Res (Phila); 2021 May; 14(5):603-614. PubMed ID: 33888515
[TBL] [Abstract][Full Text] [Related]
7. Labeled versus unlabeled discrete choice experiments in health economics: an application to colorectal cancer screening.
de Bekker-Grob EW; Hol L; Donkers B; van Dam L; Habbema JD; van Leerdam ME; Kuipers EJ; Essink-Bot ML; Steyerberg EW
Value Health; 2010; 13(2):315-23. PubMed ID: 19912597
[TBL] [Abstract][Full Text] [Related]
8. Screening for colorectal cancer: comparison of perceived test burden of guaiac-based faecal occult blood test, faecal immunochemical test and flexible sigmoidoscopy.
Hol L; de Jonge V; van Leerdam ME; van Ballegooijen M; Looman CW; van Vuuren AJ; Reijerink JC; Habbema JD; Essink-Bot ML; Kuipers EJ
Eur J Cancer; 2010 Jul; 46(11):2059-66. PubMed ID: 20621736
[TBL] [Abstract][Full Text] [Related]
9. Patient preferences for colorectal cancer screening.
Leard LE; Savides TJ; Ganiats TG
J Fam Pract; 1997 Sep; 45(3):211-8. PubMed ID: 9300000
[TBL] [Abstract][Full Text] [Related]
10. Evaluating preferences for colorectal cancer screening in individuals under age 50 using the Analytic Hierarchy Process.
Hyams T; Golden B; Sammarco J; Sultan S; King-Marshall E; Wang MQ; Curbow B
BMC Health Serv Res; 2021 Jul; 21(1):754. PubMed ID: 34325701
[TBL] [Abstract][Full Text] [Related]
11. Colorectal cancer screening mode preferences among US veterans.
Powell AA; Burgess DJ; Vernon SW; Griffin JM; Grill JP; Noorbaloochi S; Partin MR
Prev Med; 2009 Nov; 49(5):442-8. PubMed ID: 19747502
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the knowledge, behavior and health beliefs of individuals over 50 regarding colorectal cancer screening.
Tastan S; Andsoy II; Iyigun E
Asian Pac J Cancer Prev; 2013; 14(9):5157-63. PubMed ID: 24175793
[TBL] [Abstract][Full Text] [Related]
13. Validation of self-reported colorectal cancer screening behavior from a mixed-mode survey of veterans.
Partin MR; Grill J; Noorbaloochi S; Powell AA; Burgess DJ; Vernon SW; Halek K; Griffin JM; van Ryn M; Fisher DA
Cancer Epidemiol Biomarkers Prev; 2008 Apr; 17(4):768-76. PubMed ID: 18381474
[TBL] [Abstract][Full Text] [Related]
14. Comparison of guaiac and immunological fecal occult blood tests in colorectal cancer screening: the patient perspective.
Deutekom M; van Rossum LG; van Rijn AF; Laheij RJ; Fockens P; Bossuyt PM; Dekker E; Jansen JB
Scand J Gastroenterol; 2010 Nov; 45(11):1345-9. PubMed ID: 20560814
[TBL] [Abstract][Full Text] [Related]
15. Preferences for colorectal cancer screening strategies: a discrete choice experiment.
Hol L; de Bekker-Grob EW; van Dam L; Donkers B; Kuipers EJ; Habbema JD; Steyerberg EW; van Leerdam ME; Essink-Bot ML
Br J Cancer; 2010 Mar; 102(6):972-80. PubMed ID: 20197766
[TBL] [Abstract][Full Text] [Related]
16. Measuring patient preferences for colorectal cancer screening using a choice-format survey.
Marshall DA; Johnson FR; Phillips KA; Marshall JK; Thabane L; Kulin NA
Value Health; 2007; 10(5):415-30. PubMed ID: 17888107
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the benefits, harms and cost-effectiveness of potential alternatives to iFOBT testing for colorectal cancer screening in Australia.
Lew JB; St John DJB; Macrae FA; Emery JD; Ee HC; Jenkins MA; He E; Grogan P; Caruana M; Sarfati D; Greuter MJE; Coupé VMH; Canfell K
Int J Cancer; 2018 Jul; 143(2):269-282. PubMed ID: 29441568
[TBL] [Abstract][Full Text] [Related]
18. Clinical use of CT colonography for colorectal cancer screening in military training facilities and potential impact on HEDIS measures.
Cash BD; Stamps K; McFarland EG; Spiegel AR; Wade SW
J Am Coll Radiol; 2013 Jan; 10(1):30-6. PubMed ID: 23290671
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer screening with faecal immunochemical testing, sigmoidoscopy or colonoscopy: a clinical practice guideline.
Helsingen LM; Vandvik PO; Jodal HC; Agoritsas T; Lytvyn L; Anderson JC; Auer R; Murphy SB; Almadi MA; Corley DA; Quinlan C; Fuchs JM; McKinnon A; Qaseem A; Heen AF; Siemieniuk RAC; Kalager M; Usher-Smith JA; Lansdorp-Vogelaar I; Bretthauer M; Guyatt G
BMJ; 2019 Oct; 367():l5515. PubMed ID: 31578196
[TBL] [Abstract][Full Text] [Related]
20. Health benefits and cost-effectiveness of a hybrid screening strategy for colorectal cancer.
Dinh T; Ladabaum U; Alperin P; Caldwell C; Smith R; Levin TR
Clin Gastroenterol Hepatol; 2013 Sep; 11(9):1158-66. PubMed ID: 23542330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
